BBIO
BridgeBio Pharma Inc
66.60$
-1.0%
vs. previous close
Closing price · As of: Sep 18, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of BridgeBio Pharma Inc (BBIO) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 08/31/2026 | Current report (8-K) | BridgeBio Pharma, Inc. (BBIO): Other Events; Financial Statements and Exhibits | View report ↗ |
| 08/19/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 08/18/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 08/17/2026 | Current report (8-K) | BridgeBio Pharma, Inc. (BBIO): Entry into a Material Definitive Agreement; Other Events; Financial Statements and Exhibits | View report ↗ |
| 08/17/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 08/10/2026 | Current report (8-K) | BridgeBio Pharma, Inc. (BBIO): Results of Operations and Financial Condition; Financial Statements and Exhibits | View report ↗ |
| 07/22/2026 | Current report (8-K) | BridgeBio Pharma, Inc. (BBIO): Other Events; Financial Statements and Exhibits | View report ↗ |
| 07/09/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 07/09/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.